>全球非处方 (OTC) 药物市场，按产品类型（咳嗽、感冒和流感产品、止痛药、皮肤病产品、胃肠道产品、维生素、矿物质和补充剂 (VMS)、减肥/减肥产品、眼科产品、助眠产品、其他产品类型）、剂型（片剂、硬胶囊、粉末、软膏、软胶囊、液体、其他）、类别（品牌药、仿制药）、分销渠道（医院药房、零售药房、网上药房、其他分销渠道）划分 - 行业趋势和预测至 2029 年
市场分析和见解
非处方药在全球医疗保健体系中发挥着越来越重要的作用。非处方药（OTC）又称非处方药，是指无需医生处方即可在药店和当地商店购买的有效且安全的药物。
- 这些药物广泛用于治疗常见疾病，药剂师在核实顾客身份和年龄后会发放这些药物。Data Bridge Market Research 分析称，非处方 (OTC) 药物市场在 2022 年至 2029 年的预测期内预计将增长 7.50%。
非处方药 (OTC) 市场动态
驱动程序
- 新冠肺炎疫情的出现
冠状病毒影响了非处方药的销售，因为它在疫情期间增加了人们对个人健康的关注。全球范围内感冒和流感产品以及维生素摄入量的增加是推动非处方药 (OTC) 市场增长的主要因素之一。
-
非处方药供应广泛
针对多种常见疾病的非处方药供应和制造业的增加加速了市场的增长。
-
为研究人员开发新干预措施提供资金支持
各种公共和私人组织正在加大对开发新干预措施和治疗方法的投资，以增强非处方药（OTC）市场。
-
常见流感发生情况
人群中常见流感、感冒的增多，进一步影响了市场。
此外，技术的发展、庞大的患者群体和卓越的技术、对有效疗法的需求增加、医疗保健支出和成本效益的激增、积极的结果和更广泛的可及性都对非处方药 (OTC) 市场产生了积极影响。
机会
此外，对维生素补充剂和减肥产品的需求激增，为 2022 年至 2029 年预测期内的市场参与者带来了盈利机会。此外，产品供应的进一步扩大将进一步促进非处方 (OTC) 药市场的增长。
限制/挑战
On the other hand, restrictions in some regions to counteract stockpiling and maintain supply are expected to obstruct the market growth. The long-time approvals are projected to challenge the over-the-counter (OTC) medications market in the forecast period of 2022-2029.
This over-the-counter (OTC) medications market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on over-the-counter (OTC) medications market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Vitamin A deficiency is known to affect over 150 million preschool-aged children, according to the Centers for Disease Control and Prevention. About 1.8 billion people have insufficient iodine intake across the globe.
The oncogene inhibitors market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Covid-19 Impact on Over-the-Counter (OTC) Medications Market
Emergence of COVID-19 has affected several industrial sectors. However, COVID-19 had a positive impact on the over the counter (OTC) medications market as the increased focus on personal health increased during pandemic. There was a rise in the intake of cold and flu products along with vitamins among population across the globe.
Global Over-the-Counter (OTC) Medications Market Scope
The over-the-counter (OTC) medications market is segmented on the basis of product type, dosage form, category and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Cough
- Cold, and Flu Products
- Analgesics
- Dermatology Products
- Gastrointestinal Products
- Vitamins, Mineral, and Supplements (VMS)
- Weight-loss/Dietary Products
- Ophthalmic Products
- Sleeping Aids
- Other Product Types
根据产品类型，非处方药（OTC）市场分为咳嗽、感冒和流感产品、止痛药、皮肤病产品、胃肠道产品、维生素、矿物质和补充剂（VMS）、减肥/膳食产品、眼科产品、助眠产品和其他产品类型。
剂型
- 平板电脑
- 硬胶囊
- 粉末
- 软膏
- 软胶囊
- 液体
- 其他的
根据剂型，非处方药（OTC）市场分为片剂、硬胶囊、粉剂、软膏、软胶囊、液体和其他。
类别
- 品牌
- 仿制药
根据类别，非处方药（OTC）市场分为品牌药和仿制药。
分销渠道
- 医院药房
- 零售药店
- 网上药店
- 其他分销渠道
根据分销渠道，非处方药（OTC）市场分为医院药房、零售药店、网上药店和其他分销渠道。
管道分析
2009 年至 2018 年期间，私人非处方药 (OTC) 的销售额从 26% 增长到 31%。非处方药的在线销售额也在逐年增长。强生服务公司、诺华公司、拜耳公司、赛诺菲安万特美国有限责任公司和辉瑞公司等都是参与开发 OTC 药物的制造商。
监管框架：非处方药 (OTC) 市场
CDER 的非处方药办公室通常负责 FDA 对非处方药的审查。非处方药咨询委员会通过定期与各机构会面来评估这些产品的相关问题。FDA 负责审查 80 多种治疗类药物的标签和活性成分，包括 300,000 多种上市的非处方药产品。
非处方药 (OTC) 市场区域分析/见解
对非处方药（OTC）市场进行了分析，并按国家、产品类型、剂型、类别和分销渠道提供了市场规模洞察和趋势，如上所述。
非处方药（OTC）市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区（APAC）的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区（APAC）的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲（MEA）的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于北美地区药物认知度高且可支配收入高，北美在非处方药 (OTC) 市场占据主导地位。
由于该地区研发活动的激增，预计亚太地区在 2022 年至 2029 年的预测期内将实现高速增长。
报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。
竞争格局和非处方药 (OTC) 市场份额分析
非处方药 (OTC) 市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对非处方药 (OTC) 市场的关注有关。
非处方药 (OTC) 市场的一些主要参与者包括强生服务公司、诺华公司、拜耳公司、赛诺菲美国有限责任公司、辉瑞公司、葛兰素史克公司、百利戈公司、利洁时集团、武田制药有限公司、Alkem Labs、太阳制药工业有限公司、西普拉公司、梯瓦制药工业有限公司、雷迪博士实验室有限公司、Piramal Enterprises、默克公司和罗氏公司等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
